4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-24-000073
Chief Executive Officer sold 12,115 shares at $48.84 ($591,697)
- Chief Executive Officer acquired 25,527 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Goff Brian · Chief Executive Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-06-05 | Exercise or conversion : show line 1 in the form 10b5-1 | +25,527 | 79,307 | D | ||
| 2024-06-05 | Sale : show line 2 in the form 10b5-1 | −12,115 | $48.84 | $591,697 | 67,192 | D |
| Open-market sales · 12,115 sh · avg $48.84 · $591,697 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-06-05 | Exercise or conversion : show line 3 in the form 10b5-1 Performance share units | −25,527 | 76,583 | D |
Loading xslF345X05/wk-form4_1717791913.xml…